Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · IEX Real-Time Price · USD
1.540
-0.060 (-3.75%)
At close: Apr 25, 2024, 4:00 PM
1.550
+0.010 (0.65%)
After-hours: Apr 25, 2024, 7:59 PM EDT
Lexicon Pharmaceuticals Market Cap
Lexicon Pharmaceuticals has a market cap or net worth of $379.20 million as of April 25, 2024. Its market cap has decreased by -22.72% in one year.
Market Cap
379.20M
Enterprise Value
313.95M
1-Year Change
-22.72%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $379.20M, a decrease of -57.44%. That is a compound annual growth rate of -3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2024 | 394.00M | -0.61% |
| Apr 23, 2024 | 396.40M | -5.87% |
| Apr 22, 2024 | 421.10M | 3.64% |
| Apr 19, 2024 | 406.30M | 1.22% |
| Apr 18, 2024 | 401.40M | 0.63% |
| Apr 17, 2024 | 398.90M | -4.43% |
| Apr 16, 2024 | 417.40M | -9.36% |
| Apr 15, 2024 | 460.50M | -5.07% |
| Apr 12, 2024 | 485.10M | -2.96% |
| Apr 11, 2024 | 499.90M | 0.50% |
| Apr 10, 2024 | 497.40M | -2.41% |
| Apr 9, 2024 | 509.70M | -0.95% |
| Apr 8, 2024 | 514.60M | 1.46% |
| Apr 5, 2024 | 507.20M | - |
| Apr 4, 2024 | 507.20M | 0.98% |
| Apr 3, 2024 | 502.30M | -7.70% |
| Apr 2, 2024 | 544.20M | -3.06% |
| Apr 1, 2024 | 561.40M | -5.01% |
| Mar 28, 2024 | 591.00M | 9.59% |
| Mar 27, 2024 | 539.30M | 10.63% |
| Mar 26, 2024 | 487.50M | -6.61% |
| Mar 25, 2024 | 522.00M | -5.69% |
| Mar 22, 2024 | 553.50M | -6.23% |
| Mar 21, 2024 | 590.30M | -3.21% |
| Mar 20, 2024 | 609.90M | 2.06% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Community Health Systems | 404.74M |
| Neurogene | 400.63M |
| Lexeo Therapeutics | 399.98M |
| Contineum Therapeutics | 399.83M |
| NeuroPace | 397.11M |
| Corbus Pharmaceuticals Holdings | 396.01M |
| Cibus | 396.00M |
| MaxCyte | 395.69M |